Marijuana Scholar

Marijuana ScholarMarijuana ScholarMarijuana Scholar
  • Home
  • Transportation
    • Driving Performance
    • Motor Vehicle Crashes
    • Adolescence and Driving
    • Safety Policy
  • Regulation/Policy
    • History of Cannabis
    • Cannabis Derived Products
    • Cannabis Intoxication
    • Cannabis-Based Medication
    • Synthetic Cannabinoids
    • Prevalence of Use
    • U.S. Regulation/Policies
    • Public Opinions
    • Benefits of Regulation
  • Health
    • Cancer
    • Cardiometabolic Risk
    • Respiratory Disease
    • Immunity
    • Injury and Death
    • Youth & Pre/Peri/Neonatal
    • Physical Effects
    • Schizophrenia/Other
    • Bipolar Disorder
    • Suicide
    • Anxiety, Depression, PTSD
    • Problematic Use
  • Therapeutic Effects
    • Chronic Pain
    • Cancer and Chemo
    • Anorexia and Weight Loss
    • Irritable Bowel Syndrome
    • Epilepsy
    • Spasticity MS/Spinal Cord
    • Tourette Syndrome
    • ALS
    • Huntington's Disease
    • Parkinson's Disease
    • Dystonia
    • Dementia
    • Glaucoma
    • Brain Injury/Hemorrhage
    • Addiction
    • Anxiety, Depression, PTSD
    • Sleep Disorders
    • Psychoses
  • Psychosocial
    • Cognition & Academics
    • Employment and Income
    • Social Relationships/Role
    • Crimes
  • Marijuana Scholar Videos
  • More
    • Home
    • Transportation
      • Driving Performance
      • Motor Vehicle Crashes
      • Adolescence and Driving
      • Safety Policy
    • Regulation/Policy
      • History of Cannabis
      • Cannabis Derived Products
      • Cannabis Intoxication
      • Cannabis-Based Medication
      • Synthetic Cannabinoids
      • Prevalence of Use
      • U.S. Regulation/Policies
      • Public Opinions
      • Benefits of Regulation
    • Health
      • Cancer
      • Cardiometabolic Risk
      • Respiratory Disease
      • Immunity
      • Injury and Death
      • Youth & Pre/Peri/Neonatal
      • Physical Effects
      • Schizophrenia/Other
      • Bipolar Disorder
      • Suicide
      • Anxiety, Depression, PTSD
      • Problematic Use
    • Therapeutic Effects
      • Chronic Pain
      • Cancer and Chemo
      • Anorexia and Weight Loss
      • Irritable Bowel Syndrome
      • Epilepsy
      • Spasticity MS/Spinal Cord
      • Tourette Syndrome
      • ALS
      • Huntington's Disease
      • Parkinson's Disease
      • Dystonia
      • Dementia
      • Glaucoma
      • Brain Injury/Hemorrhage
      • Addiction
      • Anxiety, Depression, PTSD
      • Sleep Disorders
      • Psychoses
    • Psychosocial
      • Cognition & Academics
      • Employment and Income
      • Social Relationships/Role
      • Crimes
    • Marijuana Scholar Videos

Marijuana Scholar

Marijuana ScholarMarijuana ScholarMarijuana Scholar
  • Home
  • Transportation
    • Driving Performance
    • Motor Vehicle Crashes
    • Adolescence and Driving
    • Safety Policy
  • Regulation/Policy
    • History of Cannabis
    • Cannabis Derived Products
    • Cannabis Intoxication
    • Cannabis-Based Medication
    • Synthetic Cannabinoids
    • Prevalence of Use
    • U.S. Regulation/Policies
    • Public Opinions
    • Benefits of Regulation
  • Health
    • Cancer
    • Cardiometabolic Risk
    • Respiratory Disease
    • Immunity
    • Injury and Death
    • Youth & Pre/Peri/Neonatal
    • Physical Effects
    • Schizophrenia/Other
    • Bipolar Disorder
    • Suicide
    • Anxiety, Depression, PTSD
    • Problematic Use
  • Therapeutic Effects
    • Chronic Pain
    • Cancer and Chemo
    • Anorexia and Weight Loss
    • Irritable Bowel Syndrome
    • Epilepsy
    • Spasticity MS/Spinal Cord
    • Tourette Syndrome
    • ALS
    • Huntington's Disease
    • Parkinson's Disease
    • Dystonia
    • Dementia
    • Glaucoma
    • Brain Injury/Hemorrhage
    • Addiction
    • Anxiety, Depression, PTSD
    • Sleep Disorders
    • Psychoses
  • Psychosocial
    • Cognition & Academics
    • Employment and Income
    • Social Relationships/Role
    • Crimes
  • Marijuana Scholar Videos

Spasticity: Multiple Sclerosis or Spinal Cord Injury

Very simply, spasticity occurs when an individual's muscles continue to contract. The contraction of muscles not only causes muscle tightness but also stiffness, which interferes with both walking and normal movement. Its origin is equated to damage to the areas around the spinal cord and brain, specifically sections that control voluntary movement. Multiple symptoms may occur, including muscle spasms, involuntary leg crossing, pressure sores, muscle fatigue, and weakness in pressure sores. Again, causes are typically associated with nerve signal damage and muscle tone increases. Underlying conditions may include cerebral palsy, traumatic brain injury, and multiple sclerosis. In addition to physical features, potential mental effects may include anxiety, fatigue, and a reduction in daily activities. Regarding medical cannabis, THC is represented as one of the main cannabinoids and has been shown to improve spasticity in patients with multiple sclerosis. Importantly, clinical trials have shown mixed effects regarding medical cannabis for spasticity. While medical marijuana may treat stiff muscles, muscle spasms, pain, anxiety, and depression, it is important to recognize that both multiple sclerosis and spinal cord injuries require long-term medical care. Generally, best strains have not been related to specific conditions, but rather identified symptoms such as pain, inflammation, anxiety, and sleep. This section will address this important issue. The focus will be on the identification of clinical trials and peer-reviewed research.

Supporting Articles

The effect of cannabis-based medicine on neuropathic pain and spasticity in patients

Hansen, J. S., Hansen, R. M., Petersen, T., Gustavsen, S., Oturai, A. B., Sellebjerg, F., Sædder, E. A., Kasch, H., Rasmussen, P. V., Finnerup, N. B., & Svendsen, K. B. (2021). The effect of cannabis-based medicine on neuropathic pain and spasticity in patients with multiple sclerosis and spinal cord injury: Study protocol of a national multicenter double-blinded, placebo-controlled trial. Brain Sciences, 11(9), 1212. https://doi.org/10.3390/brainsci11091212 

Cannabinoids for spasticity due to multiple sclerosis or paraplegia

da Rovare, V. P., Magalhães, G. P. A., Jardini, G. D. A., Beraldo, M. L., Gameiro, M. O., Agarwal, A., Luvizutto, G. J., Paula-Ramos, L., Camargo, S. E. A., de Oliveira, L. D., Bazan, R., & El Dib, R. (2017). Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review and meta-analysis of randomized clinical trials. Complementary Therapies in Medicine, 34, 170-185. https://doi.org/10.1016/j.ctim.2017.08.010 

The biology that underpins the therapeutic potential of cannabis-based medicines for the control of

Baker, D., Pryce, G., Jackson, S. J., Bolton, C., & Giovannoni, G. (2012). The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis. Multiple Sclerosis and Related Disorders, 1(2), 64-75. https://doi.org/10.1016/j.msard.2011.11.001 

Copyright © 2023 Marijuana Scholar - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept